Latest Breaking News On - Mark nicolas - Page 1 : comparemela.com

Font Size: Johnson & Johnson’s one-dose vaccine is effective in preventing severe and fatal coronavirus cases, and may reduce the virus’s transmission among vaccinated people, the FDA said in new analyses Wednesday. The drug maker announced in January that its vaccine was 72% effective against the virus in the United States and 64% effective in South Africa, where a mutated, more transmissible strain has become dominant. Its vaccine was 86% effective in preventing severe virus cases in the U.S., meaning that a vaccinated individual is at a far smaller risk of being hospitalized or dying from COVID-19. The recent FDA analyses mean that a third effective vaccine could become available for Americans, potentially mitigating the widespread supply shortages reported by many states and municipalities. If the FDA emergency authorization process mirrors that of Pfizer and Moderna’s vaccines, both approved in December, then Johnson & Johnson’s vaccine could be recommended for appro

South africaThomas jefferson university hospitalUnited statesMark nicolasJeff doucetteJefferson healthDaily caller news foundationJanssen pharmaceuticalsChief nursing officerJefferson healths cherry hillGetty imagesRichard nettlesதாமஸ் ஜெஃபர்சன் பல்கலைக்கழகம் மருத்துவமனைஒன்றுபட்டது மாநிலங்களில்குறி நிக்கோலாஸ்ஜெஃப் டூசெட்